Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System

NCT00520130 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

92

Enrollment

NIH

Sponsor class

Conditions

Myelodysplastic Syndrome
Hodgkin's Lymphoma
Non-Hodgkin's Disease
Acute Leukemia
Multiple Myeloma

Interventions

BIOLOGICAL: Rituximab
DRUG: Cyclosporine
DRUG: Allogenic stem cell transplant (ASCT)
DRUG: Conditioning Chemotherapy
DRUG: TMS
DRUG: FLAG
DRUG: EPOCH-F
BIOLOGICAL: Alemtuzumab

Sponsor

National Cancer Institute (NCI)